Neurologic crises in hereditary tyrosinemia.

On the enzymic defects in hereditary tyrosinemia.

Visceral pathology of hereditary tyrosinemia type I.

Hematin therapy for the neurologic crisis of tyrosinemia.

A syndrome of hereditary tyrosinemia in mink (Mustela vison Schreb.).

Diagnosis and treatment of hereditary tyrosinemia in Japan.

Liver transplantation for hereditary tyrosinemia: the Quebec experience.

Hereditary tyrosinemia type 1 in Turkey: twenty year single-center experience.

Case of hepatocellular carcinoma in a patient with hereditary tyrosinemia in the post-newborn screening era.

Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.

Urinary p-tyramine in hereditary tyrosinemia: II. Origin of urinary p-tyramine.

Homotransplantation of the liver in a patient with hepatoma and hereditary tyrosinemia.

The effects of early treatment of hereditary tyrosinemia type I in infancy by orthotopic liver transplantation.

Heat shock response associated with hepatocarcinogenesis in a murine model of hereditary tyrosinemia type I.

Geographical and Ethnic Distribution of Mutations of the Fumarylacetoacetate Hydrolase Gene in Hereditary Tyrosinemia Type 1.

Tyrosinemia.

A Case Report of a Very Rare Association of Tyrosinemia type I and Pancreatitis Mimicking Neurologic Crisis of Tyrosinemia Type I.

Liver transplantation for hereditary tyrosinemia--early transplantation following the patient's stabilization.

Hereditary tyrosinemia of chronic course without rickets and renal tubular dysfunction.

Fumarylacetoacetase measurement as a mass-screening procedure for hereditary tyrosinemia type I.

Experience of a Single Center in NTBC Use in Management of Hereditary Tyrosinemia Type I in Libya.

Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I).

Identification of circulating microRNAs during the liver neoplastic process in a murine model of hereditary tyrosinemia type 1.

Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient.

Oculogyric Crises.

Suggest Documents

On the enzymic defects in hereditary tyrosinemia.

Visceral pathology of hereditary tyrosinemia type I.

Hematin therapy for the neurologic crisis of tyrosinemia.

A syndrome of hereditary tyrosinemia in mink (Mustela vison Schreb.).

Diagnosis and treatment of hereditary tyrosinemia in Japan.

Liver transplantation for hereditary tyrosinemia: the Quebec experience.

Hereditary tyrosinemia type 1 in Turkey: twenty year single-center experience.

Case of hepatocellular carcinoma in a patient with hereditary tyrosinemia in the post-newborn screening era.

Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.

Urinary p-tyramine in hereditary tyrosinemia: II. Origin of urinary p-tyramine.

Homotransplantation of the liver in a patient with hepatoma and hereditary tyrosinemia.

The effects of early treatment of hereditary tyrosinemia type I in infancy by orthotopic liver transplantation.

Heat shock response associated with hepatocarcinogenesis in a murine model of hereditary tyrosinemia type I.

Geographical and Ethnic Distribution of Mutations of the Fumarylacetoacetate Hydrolase Gene in Hereditary Tyrosinemia Type 1.

Tyrosinemia.

A Case Report of a Very Rare Association of Tyrosinemia type I and Pancreatitis Mimicking Neurologic Crisis of Tyrosinemia Type I.

Liver transplantation for hereditary tyrosinemia--early transplantation following the patient's stabilization.

Hereditary tyrosinemia of chronic course without rickets and renal tubular dysfunction.

Fumarylacetoacetase measurement as a mass-screening procedure for hereditary tyrosinemia type I.

Experience of a Single Center in NTBC Use in Management of Hereditary Tyrosinemia Type I in Libya.

Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I).

Identification of circulating microRNAs during the liver neoplastic process in a murine model of hereditary tyrosinemia type 1.

Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient.

Oculogyric Crises.

Neurologic crises in hereditary tyrosinemia.

Recommend Documents

Follow Us